Form 8-K - Current report:
SEC Accession No. 0001213900-16-019421
Filing Date
2016-12-14
Accepted
2016-12-14 17:13:00
Documents
2
Period of Report
2016-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k121316_actiniumpharmace.htm 8-K 16549
2 FOURTH AMENDMENT TO THE 2013 AMENDED AND RESTATED STOCK PLAN, EFFECTIVE AS OF DE f8k121316ex1i_actiniumpharma.htm EX-1.1 5592
  Complete submission text file 0001213900-16-019421.txt   23352
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 162051770
SIC: 2834 Pharmaceutical Preparations